DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* ONCODESIGN *


 

1995 - Rhône-Alpes
Dijon
www.oncodesign.fr

 

Contract, Research
(also, Discovery, Therapies)
Key words: In-vivo screening, Nude-rat, Cancer, Drug resistance, Translational research, Neurology
Mission: to provide third parties with preclinical evaluation of novel anticancer therapeutics and to identify and validate molecular targets involved in cancer pathologies
Clients: Pharmaceutical industry
contact@oncodesign.com

Age: 22 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Genne (Philippe) [co-founder, born 1961, Ph.D.]
Sc.Dir.-CSO:
Fin.Dir.-CFO:
BusDev: Ewing (Jonathan)
Financers (Hist.): CDC, Avenir Entreprise Gestion, Banque de Vizille

Turnover (M€) : 5.66 (2011), 4.56 (2010), 3.8 (2009), 4.69 (2008), 5.5 (2007)
Total funding (M€) : n.a.
Last funding (M€) : 3.0
Focus : Studies
Position : Subcontractor
Company confirm : none

 

History
DATEMILESTONETYPETIME
2012 .09 Partnering R&D agreement with Sanofi for the application of Oncodesign’s Nanocyclix technology to kinase targets R&D [17 years]
2012 .01 Partnering R&D agreement with Ipsen on LRRK2 Parkinson's disease target R&D [17 years]
2011 .10 Partnering development and distribution agreement with Taconic (USA) for solutions to advance oncology research MKTG [16 years]
2010 .06 Licensing-in of macrocyclic chemistry technology from Janssen LICIN [15 years]
2009 .08 Financing (no interest loan) : 10.0 M€, by OSEO Innovation, for oncology biomarker program IMAkinib (with Guerbet and Ariana Pharmaceuticals) DEBT [14 years]
2008 .06 Round-financing : 3.0 M€, by Banque de Vizille, Avenir Entreprise Gestion, in order to invest in USA and neurology RFIN [13 years]
2008 .03 Launch of Pharm'Image platform, a medical imagery pole in Dijon, with local partners (completion planned for 2010) MKTG [13 years]
2007 .07 Set-up of offices in Montréal, Canada ORGC [12 years]
1998 .07 Seed financing : 0.75 M€, by Ideb, Banque Populaire Création SFIN [3 years]
1995 .01 Company founded by Philippe Genne and Eric Solary (today Inserm), both scientists (Lab. Onco-hematology, Dijon University) ORGF [0 year]

Actualisation / Updating: 21-Nov-2012

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende